Women’s health startups should plan for reimbursement early, as limited research and evidence can make securing coverage difficult, a new report explains. The post The Reimbursement Challenges Hurting Women’s Health Companies, Per Milken Institute appeared first on MedCity News .
Vogenx’s mizagliflozin is heading into Phase 2b testing for post-bariatric hypoglycemia (PBH). Amylyx Pharmaceuticals and Recordati are developing injectable peptide drugs for this metabolic disorder, but Vogenx aims to stand apart by offering patients a different mechanism of action and…
The bottleneck in AI-enabled real-world data analysis is not computation, model architecture, or training data volume. It is the semantic layer over which the AI is trying to reason – the place where precise clinical meaning lives. The post Better…
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is that not only is this terrible for patient health, it can be more costly in…
PatientRightsAdvocate.org sued the American Medical Association this week, arguing the trade group has no valid copyright over the CPT codes that providers must use to bill for care. It follows a public letter Senator Bill Cassidy sent to the AMA…
Venrock led Aligned Marketplace’s Series A round. In total, the company has raised $31 million to date. The post Aligned Marketplace Secures $20M for Advanced Primary Care Marketplace appeared first on MedCity News .
Bristol Myers Squibb’s Zenbexus is the first FDA-approved drug in a new class of cancer drugs called CELMoDs. The pharma company is positioning this molecule as a successor to its legacy products for multiple myeloma. The post Bristol Myers Squibb…
Most younger professionals entering the workforce have little visibility into interoperability, digital health infrastructure, or healthcare data architecture as career pathways. The post Healthcare Keeps Buying AI. But Nobody’s Building the Workforce to Run It. appeared first on MedCity News…
Coverage for hundreds of thousands of Arkansas Medicaid enrollees next year is in question after the Trump administration refused to renew a key state waiver. The state might not be the last to have to adjust to an arcane rule…
Some seriously ill patients improve on hospice. About 1 in 16 patients enrolled in hospice care lose eligibility as a result. Here’s how to get appropriate care after receiving a terminal diagnosis.
A court ruling struck down key parts of how regulators calculate the No Surprises Act’s qualifying payment amount, siding with the Texas Medical Association’s argument that the formula has historically favored payers in arbitration. The post Appeals Court Sides with…